3 mins
The key to natural looking results
Individualised strategies are becoming critical for full-face aesthetics, especially for rejuvenating the ageing face. The lower third is very important for a desirable facial appearance. The aesthetic goal of the rejuvenation approach is to redefine the mandibular angle and line. Among the many dermal fillers currently available, Restylane Lyft is specifically designed to deliver projection and structure for a pronounced effect without volumising.1-3 Restylane Lyft delivers natural-looking results, thanks to the science behind it.
BEAUTIFULLY VERSATILE
Experience in practice has shown that Restylane Lyft can be used in the cheeks, nose, jawline, and chin, creating sharp and sculpted results without adding volume, for natural-looking contours. Patients could expect to see more defined cheeks, sharper jawlines, projected chins, and improvements to noses that enhance their overall profile. In terms of the durability, Restylane Lyft has been shown to deliver up to 24 months of sustained aesthetic improvement following one re-treatment.4* in the Restylane range for considerable resistance to deformation.1 This enables targeted tissue integration and minimal distribution, for tailored treatment with precise and pronounced lifting capacity.7,10,11
Before and After Emily: Treated with 0.7mL of Restylane Lyft and 0.5mL of Restylane Defyne in the chin • 0.5mL of Restylane Defyne in the nasolabial folds • 1mL of Restylane Kysse in the lips.
WHAT DO PATIENTS THINK?
• 100% of patients said their results were natural looking at four and eight weeks post-treatment5^^
• 96% of patients said they would have the treatment again6^
• 98% said they would recommend the treatment to a friend6^
• 88% of patients felt their results were still improved at 12 months6^
THE POWER OF PRECISION
Restylane Lyft employs NASHA technology, offering gels with minimum modifications for close composition to natural hyaluronic acid, enabling delivery of natural-looking results. Restylane Lyft has a firm gel texture and controlled particle size for greater projection,7-9 with the highest G’ in the Restylane range for considerable resistance to deformation.1 This enables targeted tissue integration and minimal distribution, for tailored treatment with precise and pronounced lifting capacity.7,10,11
SAFETY IN NUMBERS
Restylane Lyft has a well-established safety profile, with more than 20 publications involving over 1,500 patients.12,13 However, injection-related reactions might occur after treatment, consisting mainly of mild to moderate inflammatory symptoms, which generally resolve spontaneously within a few days or up to two weeks after treatment.14**
THE VOICE OF EXPERIENCE
Dr Munir Somji of Dr MediSpa says: “Restylane Lyft is ideal for my practice because it is a versatile dermal filler solution for my patients. It can be used in several areas including the chin, jawline, cheeks, and nose, providing a beautiful projection and lifting, combined with a targeted tissue integration.”
GETTING THE MOST FROM THE RESTYLANE RANGE
The ultimate projection achieved with Restylane Lyft can be complemented with other Galderma products for a Holistic Individualised Treatment (HIT). To learn more, speak with your Galderma sales representative or contact sales.UK@galderma.com.
NASHA®, Non-Animal Stabilised Hyaluronic Acid; HA, hyaluronic acid
*At 24 months 93% of patients (N=100) had self-evaluated improvements and 82% had physician-assessed improvements following one retreatment.4
*
*Please consult product instructions for full information
^ In a study of 100 Asian patients assessing facial aesthetics appearance after treatment with Restylane and Restylane Lyft in the upper cheeks, nasolabial folds, temples, nose and chin.
^^ 30 patients treated with Restylane Lyft and Restylane Volyme in the mid face.
Dr Munir Somji is akey opinion leader for Galderma. This advertorial was created and funded by Galderma. GB-RES-2400063 DOP April 2024
REFERENCES
1. Galderma. Data on File. MA-43049.
2. Nikolis A et al. Aesthet Surg J Open Forum. 2020; 2(1): ojaa005
3. Gregario G et al. Clin Cosmet Investig Dermatol 2022; 15: 681-690.
4. Huang S and Tsai T. J Drugs Dermatol 2020; 19(9): 836-842.
5. Nikolis A. AMWC poster 2022
6. Data on File. MA-40091
7. Rogerio V et al. J Stomatol Oral Maxillofac Surg. 2022;123(4):440–7.
8. Galderma. Data on file. MA-43049. xStrain and G’ (Global).
9. Galderma. Data on file. MA- 34483. xStrain and G’ (US).
10. Lundgren B et al. J Drugs Dermatol. 2018;17(9):982–6.
11. Di Gregorio Cet al. Clin Cosmet Investig Dermatol. 2022;14:681–90.
12. Data on File. MA-43602.
13. Sadeghpour M et al. DermatolSurg2019;45(8): 1085-1094.
14. Restylane Lyft Lidocaine IFU
ANY SIDE EFFECTS SHOULD BE REPORTED. FOR PATIENTS IN THE UK, FORMS AND INFORMATION CAN BE FOUND AT MHRA.GOV.UK/YELLOWCARD, OR SEARCH FOR YELLOW CARD IN GOOGLE PLAY OR THE APPLE APP STORE. IN IRELAND, SIDE EFFECTS CAN BE REPORTED VIA HPRA PHARMACOVIGILANCE AT HPRA.IE. ANY SIDE EFFECTS SHOULD ALSO BE REPORTED TO GALDERMA (UK) LTD; EMAIL MEDINFO.UK@GALDERMA.COM OR CALL 0300 303 5674.